SEC Form D filing

Immorta Bio, Inc., 2026-01-08

An SEC Form D private-offering notice from Miami Beach, FL, a $500,000 filer-stated offering target in Biotech. Filed 2026-01-08. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Immorta Bio, Inc. site↗ Verified via SEC Form D

A biotech developing senolytic immunotherapy and stem cell regenerative platforms aimed at treating diseases of aging.

Filed 2026-01-08Filed to raise $500,000First money in 2023-11-09Raised so far $450,000HQ (as filed) Miami Beach, FLSector Biotech web-verified against the company’s own siteStage (inferred) Pre-seedCall status Late filing
Source linked the Form D on EDGAR↗Website verified immortabio.com↗Named in the filing 1 executive & director

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source